resTORbio, Inc. License Agreements
10 Contracts & Agreements
- Amendment No. 2 to Amended and Restated License Agreement, dated as of January 13, 2016, by and between Technion Research and Development Foundation Ltd., Applied Immune... (Filed With SEC on September 16, 2020)
- Amendment No. 1 to Amended and Restated License Agreement, dated as of June 30, 2015, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself... (Filed With SEC on September 16, 2020)
- Amended and Restated License Agreement, dated as of May 21, 2014, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself and the... (Filed With SEC on September 16, 2020)
- Amendment No. 2 to Amended and Restated License Agreement, dated as of January 13, 2016, by and between Technion Research and Development Foundation Ltd., Applied Immune... (Filed With SEC on June 23, 2020)
- Amendment No. 1 to Amended and Restated License Agreement, dated as of June 30, 2015, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself... (Filed With SEC on June 23, 2020)
- Amended and Restated License Agreement, dated as of May 21, 2014, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself and the... (Filed With SEC on June 23, 2020)
- Amendment No. 2 to License Agreement, dated August 20, 2019, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on November 5, 2019)
- License Agreement, dated as of March 23, 2017, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on January 16, 2018)
- First Amendment to the License Agreement, dated as of October 3, 2017, by and among the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on December 29, 2017)
- License Agreement, dated as of March 23, 2017, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on December 29, 2017)
